Avalo Therapeutics AVTX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Avalo Therapeutics (AVTX) reported comprehensive income (loss), net of tax, attributable to parent of -$19.7M in Q1 2026.
- How has Avalo Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Avalo Therapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 49.9% year-over-year, from -$13.15M to -$19.7M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- The total change in equity during the period resulting from transactions and other events from non-owner sources, including net income and other comprehensive income items. This provides a holistic view of the company's financial health by incorporating both operational results and unrealized gains or losses. It serves as a comprehensive measure of the total change in the company's net worth over the reporting period.